Overview

Influence of Stimulant Medication on Brain Processes for Decision Making in Attention Deficit Hyperactivity Disorder

Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The goal of this trial is to investigate the cognitive- and brain-mechanisms underlying decision making (DM) and learning in young adults with Attention-Deficit/Hyperactivity Disorder (ADHD) as well as the modulation of task-related and task-independent brain activation by methylphenidate. The study aims at using a double-blinded, placebo controlled, cross-over, withdrawal design to study the effects of ADHD and methylphenidate in both a behavioural study investigating cognitive effects on decision making and instrumental learning, and a functional MRI (fMRI) study investigating the effects on brain mechanisms during decision making alone. A secondary objective of the trial is to measure the effect of adult ADHD and methylphenidate on cerebral perfusion. This will be done through applying a novel arterial spin labelling MRI-technique on the participants in the fMRI arm of the study.
Phase:
Phase 4
Details
Lead Sponsor:
Mats Fredriksen
Collaborators:
Norwegian Institute of Public Health
The Hospital of Vestfold
The Research Council of Norway
Treatments:
Central Nervous System Stimulants
Methylphenidate